It took 10 years to land on the moon. This team aims to 3-D print 'bioficial' heart in that time

In Louisville, Ky., the horses run fast, bourbon’s sipped slow, and the scientists, well, they dream big. Stuart Williams, the executive and scientific director at the Cardiovascular Innovation Institute, aims to be able to 3-D print a human, “bioficial,” functional heart in 10 years. It will be grown from the patient’s “own fat stem cells,” according to LiveScience.

Understanding EGPA: The Role of Eosinophils and Advancements in Treatment Options

FASENRA® (benralizumab) injection, for subcutaneous use, 30 mg is indicated for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis (EGPA). FASENRA provides a treatment option for HCPs to consider when managing this challenging disease.

By FASENRA, Sponsored Content

His lab has already begun developing the next generation of custom-built 3D printers aimed at printing out a complete heart with all its parts — heart muscle, blood vessels, heart valves and electrical tissue. . . .

“I took a step back and looked at my colleagues, and said, ‘Why don’t we build it like a large airplane?'” Williams told LiveScience. “Separate the organ into separate components, figure out the best way to make the components, and then put them together.”

In Kentucky, three in 10 deaths are from cardiovascular disease, according to the Courier-Journal.

Because of the minute scale of some necessary blood vessels, “. . . 3-D printing may only get researchers partway toward the goal of creating a complete heart. Instead, researchers will have to rely upon the natural self-organizing tendency of cells to knit together blood vessels and eventually connect everything within a 3D-printed organ — a process that could take place within 24 hours,” according to LiveScience.

Wow.